Abstract
Posaconazole is a commonly used medication for antifungal prophylaxis in patients with high-risk acute leukemia, such as acute myeloid leukemia. Despite clinical data that show that posaconazole is superior to other antifungal prophylaxis medications, posaconazole is known to have many side effects and drug-drug interactions. We present a patient who developed rhabdomyolysis after being started on posaconazole for prophylaxis in the setting of relapsed acute myeloid leukemia.
| Original language | English (US) |
|---|---|
| Journal | Journal of Investigative Medicine High Impact Case Reports |
| Volume | 5 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 2017 |
Fingerprint
Keywords
- AML
- Acute myeloid leukemia
- Posaconazole
- Rhabdomyolysis
ASJC Scopus subject areas
- Epidemiology
- Safety, Risk, Reliability and Quality
- Safety Research
Cite this
Rhabdomyolysis following initiation of posaconazole use for antifungal prophylaxis in a patient with relapsed acute myeloid leukemia : A case report. / Mody, Mayur D.; Ravindranathan, Deepak; Gill, Harpaul S.; Kota, Vamsi K.
In: Journal of Investigative Medicine High Impact Case Reports, Vol. 5, No. 1, 01.01.2017.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Rhabdomyolysis following initiation of posaconazole use for antifungal prophylaxis in a patient with relapsed acute myeloid leukemia
T2 - A case report
AU - Mody, Mayur D.
AU - Ravindranathan, Deepak
AU - Gill, Harpaul S.
AU - Kota, Vamsi K.
PY - 2017/1/1
Y1 - 2017/1/1
N2 - Posaconazole is a commonly used medication for antifungal prophylaxis in patients with high-risk acute leukemia, such as acute myeloid leukemia. Despite clinical data that show that posaconazole is superior to other antifungal prophylaxis medications, posaconazole is known to have many side effects and drug-drug interactions. We present a patient who developed rhabdomyolysis after being started on posaconazole for prophylaxis in the setting of relapsed acute myeloid leukemia.
AB - Posaconazole is a commonly used medication for antifungal prophylaxis in patients with high-risk acute leukemia, such as acute myeloid leukemia. Despite clinical data that show that posaconazole is superior to other antifungal prophylaxis medications, posaconazole is known to have many side effects and drug-drug interactions. We present a patient who developed rhabdomyolysis after being started on posaconazole for prophylaxis in the setting of relapsed acute myeloid leukemia.
KW - AML
KW - Acute myeloid leukemia
KW - Posaconazole
KW - Rhabdomyolysis
UR - http://www.scopus.com/inward/record.url?scp=85055661288&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055661288&partnerID=8YFLogxK
U2 - 10.1177/2324709617690747
DO - 10.1177/2324709617690747
M3 - Article
AN - SCOPUS:85055661288
VL - 5
JO - Journal of Investigative Medicine High Impact Case Reports
JF - Journal of Investigative Medicine High Impact Case Reports
SN - 2324-7096
IS - 1
ER -